208 related articles for article (PubMed ID: 19177313)
21. Resolution, quantification and confirmation of betamethasone and dexamethasone in equine plasma by liquid chromatography/tandem mass spectrometry.
Luo Y; Uboh CE; Soma LR; Guan F; Rudy JA; Tsang DS
Rapid Commun Mass Spectrom; 2005; 19(6):825-32. PubMed ID: 15714597
[TBL] [Abstract][Full Text] [Related]
22. Insulins in equine urine: qualitative analysis by immunoaffinity purification and liquid chromatography/tandem mass spectrometry for doping control purposes in horse-racing.
Kuuranne T; Thomas A; Leinonen A; Delahaut P; Bosseloir A; Schänzer W; Thevis M
Rapid Commun Mass Spectrom; 2008; 22(3):355-62. PubMed ID: 18181226
[TBL] [Abstract][Full Text] [Related]
23. Analytics of nonpeptidic erythropoietin mimetic agents in sports drug testing employing high-resolution/high-accuracy liquid chromatography-mass spectrometry.
Vogel M; Dib J; Tretzel L; Piper T; Thomas A; Schänzer W; Thevis M
Anal Bioanal Chem; 2016 Sep; 408(23):6431-42. PubMed ID: 27438721
[TBL] [Abstract][Full Text] [Related]
24. How to confirm C.E.R.A. doping in athletes' blood?
Leuenberger N; Lamon S; Robinson N; Giraud S; Saugy M
Forensic Sci Int; 2011 Dec; 213(1-3):101-3. PubMed ID: 21889277
[TBL] [Abstract][Full Text] [Related]
25. Validation of a screening method for corticosteroids in doping analysis by liquid chromatography/tandem mass spectrometry.
Deventer K; Delbeke FT
Rapid Commun Mass Spectrom; 2003; 17(18):2107-14. PubMed ID: 12955741
[TBL] [Abstract][Full Text] [Related]
26. Sports drug testing for erythropoiesis-stimulating agents and autologous blood transfusion.
Reichel C
Drug Test Anal; 2012 Nov; 4(11):803-4. PubMed ID: 22927317
[No Abstract] [Full Text] [Related]
27. Efficient use of retention time for the analysis of 302 drugs in equine plasma by liquid chromatography-MS/MS with scheduled multiple reaction monitoring and instant library searching for doping control.
Liu Y; Uboh CE; Soma LR; Li X; Guan F; You Y; Chen JW
Anal Chem; 2011 Sep; 83(17):6834-41. PubMed ID: 21806004
[TBL] [Abstract][Full Text] [Related]
28. Determination of human insulin and its analogues in human blood using liquid chromatography coupled to ion mobility mass spectrometry (LC-IM-MS).
Thomas A; Schänzer W; Thevis M
Drug Test Anal; 2014; 6(11-12):1125-32. PubMed ID: 25219675
[TBL] [Abstract][Full Text] [Related]
29. Preventive doping control screening analysis of prohibited substances in human urine using rapid-resolution liquid chromatography/high-resolution time-of-flight mass spectrometry.
Vonaparti A; Lyris E; Angelis YS; Panderi I; Koupparis M; Tsantili-Kakoulidou A; Peters RJ; Nielen MW; Georgakopoulos C
Rapid Commun Mass Spectrom; 2010 Jun; 24(11):1595-609. PubMed ID: 20486255
[TBL] [Abstract][Full Text] [Related]
30. Detection of peginesatide in equine serum using liquid chromatography-tandem mass spectrometry for doping control purposes.
Möller I; Thomas A; Wingender A; Machnik M; Schänzer W; Thevis M
Eur J Mass Spectrom (Chichester); 2012; 18(4):407-12. PubMed ID: 22971699
[TBL] [Abstract][Full Text] [Related]
31. High resolution separation methods for the determination of intact human erythropoiesis stimulating agents. A review.
Girard M; Puerta A; Diez-Masa JC; de Frutos M
Anal Chim Acta; 2012 Feb; 713():7-22. PubMed ID: 22200302
[TBL] [Abstract][Full Text] [Related]
32. Methods for detection and confirmation of Hematide™/peginesatide in anti-doping samples.
Leuenberger N; Saugy J; Mortensen RB; Schatz PJ; Giraud S; Saugy M
Forensic Sci Int; 2011 Dec; 213(1-3):15-9. PubMed ID: 21816551
[TBL] [Abstract][Full Text] [Related]
33. Validation and application of a screening method for beta2-agonists, anti-estrogenic substances and mesocarb in human urine using liquid chromatography/tandem mass spectrometry.
Kang MJ; Hwang YH; Lee W; Kim DH
Rapid Commun Mass Spectrom; 2007; 21(2):252-64. PubMed ID: 17171780
[TBL] [Abstract][Full Text] [Related]
34. Doping control analysis of tricyclic tetrahydroquinoline-derived selective androgen receptor modulators using liquid chromatography/electrospray ionization tandem mass spectrometry.
Thevis M; Kohler M; Thomas A; Schlörer N; Schänzer W
Rapid Commun Mass Spectrom; 2008 Aug; 22(16):2471-8. PubMed ID: 18634123
[TBL] [Abstract][Full Text] [Related]
35. Fast analysis of doping agents in urine by ultra-high-pressure liquid chromatography-quadrupole time-of-flight mass spectrometry I. Screening analysis.
Badoud F; Grata E; Perrenoud L; Avois L; Saugy M; Rudaz S; Veuthey JL
J Chromatogr A; 2009 May; 1216(20):4423-33. PubMed ID: 19342059
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, characterisation, and mass spectrometric detection of a pegylated EPO-mimetic peptide for sports drug testing purposes.
Möller I; Thomas A; Geyer H; Schänzer W; Thevis M
Rapid Commun Mass Spectrom; 2011 Aug; 25(15):2115-23. PubMed ID: 21710591
[TBL] [Abstract][Full Text] [Related]
37. Erythropoietin and erythropoiesis stimulating agents.
Debeljak N; Sytkowski AJ
Drug Test Anal; 2012 Nov; 4(11):805-12. PubMed ID: 22508651
[TBL] [Abstract][Full Text] [Related]
38. Assessing the instability of the isoelectric focusing patterns of erythropoietin in urine.
Belalcazar V; Gutiérrez Gallego R; Llop E; Segura J; Pascual JA
Electrophoresis; 2006 Nov; 27(22):4387-95. PubMed ID: 17054082
[TBL] [Abstract][Full Text] [Related]
39. Recombinant erythropoietin and analogues: a challenge for doping control.
Pascual JA; Belalcazar V; de Bolos C; Gutiérrez R; Llop E; Segura J
Ther Drug Monit; 2004 Apr; 26(2):175-9. PubMed ID: 15228161
[TBL] [Abstract][Full Text] [Related]
40. Identification of oral antidiabetics and their metabolites in human urine by liquid chromatography/tandem mass spectrometry--a matter for doping control analysis.
Thevis M; Geyer H; Schänzer W
Rapid Commun Mass Spectrom; 2005; 19(7):928-36. PubMed ID: 15747323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
